ReviewThe Journal of clinical psychiatry2024

Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies.

Mina M Rizk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.